Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

AGLE

Aeglea BioTherapeutics (AGLE)

Aeglea BioTherapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AGLE
FechaHoraFuenteTítuloSímboloCompañía
29/04/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202415:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202415:40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202415:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
02/04/202415:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AGLEAeglea BioTherapeutics Inc
01/04/202415:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AGLEAeglea BioTherapeutics Inc
20/03/202406:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AGLEAeglea BioTherapeutics Inc
18/03/202415:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:AGLEAeglea BioTherapeutics Inc
14/03/202415:12Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202315:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202307:30PR Newswire (US)Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBDNASDAQ:AGLEAeglea BioTherapeutics Inc
22/11/202316:00PR Newswire (US)Aeglea BioTherapeutics Announces Grants of Inducement AwardsNASDAQ:AGLEAeglea BioTherapeutics Inc
15/11/202316:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGLEAeglea BioTherapeutics Inc
14/11/202314:13Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AGLEAeglea BioTherapeutics Inc
09/11/202315:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGLEAeglea BioTherapeutics Inc
09/11/202315:05PR Newswire (US)Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGLEAeglea BioTherapeutics Inc
30/10/202319:00PR Newswire (US)Aeglea BioTherapeutics to Participate in Upcoming November Investor ConferencesNASDAQ:AGLEAeglea BioTherapeutics Inc
06/10/202320:40Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:AGLEAeglea BioTherapeutics Inc
14/09/202316:03PR Newswire (US)Aeglea BioTherapeutics to Participate in Upcoming September ConferenceNASDAQ:AGLEAeglea BioTherapeutics Inc
07/09/202307:40PR Newswire (US)Aeglea BioTherapeutics Announces Reverse Stock SplitNASDAQ:AGLEAeglea BioTherapeutics Inc
05/09/202306:00PR Newswire (US)Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-JonesNASDAQ:AGLEAeglea BioTherapeutics Inc
11/08/202306:00PR Newswire (US)Aeglea BioTherapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:AGLEAeglea BioTherapeutics Inc
07/08/202315:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AGLEAeglea BioTherapeutics Inc
27/07/202306:00PR Newswire (US)Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica PharmaNASDAQ:AGLEAeglea BioTherapeutics Inc
06/07/202315:04Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:AGLEAeglea BioTherapeutics Inc
30/06/202316:24Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:AGLEAeglea BioTherapeutics Inc
23/06/202315:30PR Newswire (US)Aeglea BioTherapeutics Announces Grant of Inducement AwardsNASDAQ:AGLEAeglea BioTherapeutics Inc
23/06/202308:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGLEAeglea BioTherapeutics Inc
22/06/202307:17PR Newswire (US)Aeglea BioTherapeutics Announces Acquisition of Spyre TherapeuticsNASDAQ:AGLEAeglea BioTherapeutics Inc
11/05/202306:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AGLEAeglea BioTherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AGLE

Su Consulta Reciente

Delayed Upgrade Clock